Brief: Sinopharm Group Says Qtrly Total Operating Revenue RMB145.52 Bln
April 28 (Reuters) - Sinopharm Group Co Ltd 1099.HK :
* QTRLY TOTAL OPERATING REVENUE RMB145.52 BILLION VERSUS
RMB127.60
BILLION
* QTRLY TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE RMB1.59
BILLION
VERSUS RMB1.43 BILLION
Source text for Eikon: ID:nHKS8GRMQ8
Further company coverage: 1099.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For